WeWork IPO sees 13% subscription on day 2, retail demand at 0.37xWeWork India’s ₹3,000-crore IPO saw muted demand with just 13 per cent subscription on day two. The issue, priced between ₹615 and ₹648 per share, closes on October 7 and is entirely an offer for sale, with no proceeds going to the company. Anchor investors committed ₹1,348 crore ahead of the IPO. Brokerages are cautious, citing strong brand and profitability but raising concerns over high valuations and fixed costs.Read more hereEli Lilly to ...

Two Indian drugmakers have come under regulatory scrutiny after cough syrups made by them were linked to a number of child deaths in Madhya Pradesh and Rajasthan. The central drug regulator has swung into action after finding a toxic contaminant in one of the cough syrups tested. Some states have banned the sale of these drugs. This isn’t the first time cough syrups made in India have been linked to fatalities in children. In recent years, India-made cough syrups have come under global scrutiny—they have be ...